Cited by 254T-cell and B-cell ImmunologyRenal Transplantation Outcomes and TreatmentsSignaling Pathways in Disease

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells

Open access

Coenen, Jeroen J. A., Koenen, Hans J. P. M., van Rijssen, Esther, Hilbrands, Luuk B., Joosten, Irma·2006·Blood

DOI 10.1182/blood-2005-07-3032

Open this paper in CoChat — free account Open PDF

Abstract

The immunosuppressive drugs rapamycin and cyclosporin A (CsA) are widely used to prevent allograft rejection. Moreover, they were shown to be instrumental in experimental models of tolerance induction. However, it remains to be elucidated whether these drugs have an effect on the CD4+ CD25+ regulatory T-cell (T(REG)) population, which plays an important role in allograft tolerance. Recently, we reported that alloantigen-driven expansion of human CD4+ CD25+ T(REG)s gives rise to a distinct highly suppressive CD27+ T(REG) subset next to a moderately suppressive CD27- T(REG) subset. In the current study we found that rapamycin and CsA do not interfere with the suppressive activity of human naturally occurring CD4+ CD25+ T cells. However, in contrast to CsA, rapamycin preserved the dominance of the potent CD27+ T(REG) subset over the CD27- T(REG) subset after alloantigen-driven expansion of CD4+ CD25+ T(REG)s in vitro. Accordingly, CD4+ CD25+ T(REG)s cultured in the presence of rapamycin displayed much stronger suppressive capacity than CD4+ CD25+ T(REG)s cultured in the presence of CsA. In addition, CD4+ CD25+ T(REG) cells cultured in the presence of rapamycin, but not CsA, were able to suppress ongoing alloimmune responses. This differential effect of rapamycin and CsA on the CD27+ T(REG) subset dominance may favor the use of rapamycin in tolerance-inducing strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1182/blood-2005-07-3032

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

CD4+CD25+ suppressor T cells: more questions than answers
Shevach, E. M. (2002) · Nature reviews. Immunology · doi:10.1038/nri821 · Cited by 2,097
Regulatory T cells in transplantation tolerance
Wood, K. J., & Sakaguchi, S. (2003) · Nature reviews. Immunology · doi:10.1038/nri1027 · Cited by 1,319
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
Edinger, M., Hoffmann, P., Ermann, J., Drago, K., Fathman, C. G., Strober, S., & Negrin, R. S. (2003) · Nature Medicine · doi:10.1038/nm915 · Cited by 1,286
In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes
Tang, Q., Henriksen, K., Bi, M., Finger, E. B., Szot, G. L., Ye, J., Masteller, E. L., McDevitt, H. O., Bonyhadi, M. L., & Bluestone, J. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040139 · Cited by 1,232
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.
Battaglia, M., Stabilini, A., & Roncarolo, M. (2005) · Blood · doi:10.1182/blood-2004-10-3932 · Cited by 1,203
Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
Croft, M. (2003) · Nature reviews. Immunology · doi:10.1038/nri1148 · Cited by 863
Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
Li, Y.-S., Li, X.-C., Zheng, X., Wells, A., Turka, L., & Strom, T. (1999) · Nature Medicine · doi:10.1038/15256 · Cited by 830
Tolerance, not immunity, crucially depends on IL-2
Malek, T. R., & Bayer, A. L. (2004) · Nature reviews. Immunology · doi:10.1038/nri1435 · Cited by 819
IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo
Hara, M., Kingsley, C. I., Niimi, M., Read, S., Turvey, S. E., Bushell, A., Morris, P. J., Powrie, F. M., & Wood, K. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3789 · Cited by 765
CD25+CD4+ Regulatory T Cells Prevent Graft Rejection: CTLA-4- and IL-10-Dependent Immunoregulation of Alloresponses
Kingsley, C. I., Karim, M., Bushell, A., & Wood, K. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1080 · Cited by 742

Show all 38 references

Sorted by citations

Items 101–200 of 254

Single CD28 stimulation induces stable and polyclonal expansion of human regulatory T cells
He, X., Smeets, R. L., van Rijssen, E., Boots, A. M. H., Joosten, I., & Koenen, H. J. P. M. (2017) · Scientific Reports · doi:10.1038/srep43003 · Cited by 38
Self-citation
Sirolimus as Primary Treatment of Acute Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation
Pidala, J., Kim, J., & Anasetti, C. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2009.03.020 · Cited by 38
Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab
Matthews, K., Lim, Z. Z., Afzali, B., Pearce, L., Abdallah, A. M., Kordasti, S. Y., Pagliuca, A., Lombardi, G., Madrigal, J. A., Mufti, G. J., et al. (2009) · Haematologica · doi:10.3324/haematol.2008.003103 · Cited by 37
High frequencies of CD62L+ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation
Lu, S.-Y., Liu, K.-Y., Liu, D.-H., Xu, L.-P., & Huang, X.-J. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04418.x · Cited by 36
Identification, Isolation, and Functional Assay of Regulatory T Cells
Azimi, M., Aslani, S., Mortezagholi, S., Farrokhi, A. S., Javan, M. R., Rezaiemanesh, A., Ghaedi, M., Gholamzad, M., & Salehi, E. (2016) · Immunological Investigations · doi:10.1080/08820139.2016.1193869 · Cited by 36
In Vitro Expanded Human CD4+CD25+ Regulatory T Cells are Potent Suppressors of T-Cell-Mediated Xenogeneic Responses
Wu, J., Yi, S., Ouyang, L., Jimenez, E., Simond, D. M., Wang, W., Wang, Y., Hawthorne, W. J., & O’Connell, P. J. (2008) · Transplantation · doi:10.1097/tp.0b013e3181734793 · Cited by 36
Adoptive cell therapy using antigen-specific CD4−CD8− T regulatory cells to prevent autoimmune diabetes and promote islet allograft survival in NOD mice
Zhang, D., Zhang, W., Ng, T. W., Wang, Y., Liu, Q., Gorantla, V. S., Lakkis, F. G., & Zheng, X. X. (2011) · Diabetologia · doi:10.1007/s00125-011-2179-4 · Cited by 36
Characteristics and PD-1 expression of peripheral CD4+CD127loCD25hiFoxP3+ Treg cells in chronic HCV infected-patients
Shen, T., Zheng, J., Liang, H. L., Xu, C., Chen, X., Zhang, T., Xu, Q., & Lu, F. (2011) · Virology Journal · doi:10.1186/1743-422x-8-279 · Cited by 36
Two‐year follow‐up of a prospective study of circulating regulatory T cells in renal transplant patients
Segundo, D. S., Fernández‐Fresnedo, G., Ruiz, J. C., Rodrigo, E., Benito, M. J., Arias, M., & López‐Hoyos, M. (2009) · Clinical Transplantation · doi:10.1111/j.1399-0012.2009.01086.x · Cited by 35
Strategies for targeting T-cells in allergic diseases and asthma
Heijink, I. H., & van Oosterhout, A. J. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.005 · Cited by 36
Prevention of Graft-versus-Host Disease by Adoptive T Regulatory Therapy Is Associated with Active Repression of Peripheral Blood Toll-Like Receptor 5 mRNA Expression
Sawitzki, B., Brunstein, C. G., Meisel, C., Schumann, J., Vogt, K., Appelt, C., Curtsinger, J., Verneris, M. R., Miller, J. S., Wagner, J. E., et al. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.10.022 · Cited by 34
The effects of rapamycin on regulatory T cells: Its potential time-dependent role in inducing transplant tolerance
Shan, J., Feng, L., Li, Y., Sun, G., Chen, X., & Chen, P. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.07.006 · Cited by 34
Regulation and Privilege in Transplantation Tolerance
Waldmann, H., Adams, E., Fairchild, P. J., & Cobbold, S. P. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9249-5 · Cited by 34
Targeting PKC in Human T Cells Using Sotrastaurin (AEB071) Preserves Regulatory T Cells and Prevents IL-17 Production
He, X., Koenen, H. J. P. M., Smeets, R. L., Keijsers, R., van Rijssen, E., Koerber, A., van de Kerkhof, P. C., Boots, A. M. H., & Joosten, I. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.459 · Cited by 33
Self-citation
Immunoregulatory profiles in liver transplant recipients on different immunosuppressive agents
Levitsky, J., Miller, J., Wang, E., Rosen, A. L., FLAA, C., Abecassis, M. M., Mathew, J. M., & Tambur, A. R. (2009) · Human Immunology · doi:10.1016/j.humimm.2008.12.008 · Cited by 33
Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells
Zwang, N. A., & Leventhal, J. R. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016111206 · Cited by 32
Spectrum of T‐lymphocyte activities regulating allergic lung inflammation
Gelfand, E. W., Joetham, A., Wang, M., Takeda, K., & Schedel, M. (2017) · Immunological Reviews · doi:10.1111/imr.12561 · Cited by 32
Calcineurin Inhibitors Block MHC-Restricted Antigen Presentation In Vivo
Lee, Y., Lee, Y.-R., Im, S., Park, S.-I., Kim, K., Gerelchuluun, T., Song, S., Kim, K., & Lee, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.5711 · Cited by 32
Severe FOXP3+ and Naïve T Lymphopenia in a Non-IPEX Form of Autoimmune Enteropathy Combined With an Immunodeficiency
Zuber, J., Viguier, M. A., Lemaı̂tre, F., Senée, V., Patey, N., Elain, G., Geissmann, F., Fakhouri, F., Ferradini, L., Julier, C., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.034 · Cited by 31
Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation
Michelo, C. M., Fasse, E., van Cranenbroek, B., Linda, K., van der Meer, A., Abdelrazik, H., & Joosten, I. (2016) · Transplant Immunology · doi:10.1016/j.trim.2016.04.008 · Cited by 33
Self-citation
The intragraft vascularized bone marrow component plays a critical role in tolerance induction after reconstructive transplantation
Lin, C., Anggelia, M. R., Cheng, H.-Y., Wang, A. Y. L., Chuang, W., Lin, C., Lee, W. P. A., Wei, F., & Brandacher, G. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0325-y · Cited by 30
Everolimus improves experimental autoimmune uveoretinitis
Hennig, M. M., Bauer, D., Wasmuth, S., Busch, M., Walscheid, K., Thanos, S., & Heiligenhaus, A. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.09.003 · Cited by 29
Generation of Donor-Specific Regulatory T-Cell Function in Kidney Transplant Patients
Hendrikx, T. K., van Gurp, E. A. F. J., Sewgobind, V. D. K. D., Mol, W. M., Schoordijk, W., Klepper, M., Velthuis, J. H. L., Geel, A., IJzermans, J. N. M., Weimar, W., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e3181901b69 · Cited by 28
Immunosuppressive Compounds Exhibit Particular Effects on Functional Properties of Human Anti-Aspergillus T H 1 Cells
Tramsen, L., Schmidt, S., Roeger, F., Schubert, R., Salzmann‐Manrique, E., Latgé, J., Klingebiel, T. E., & Lehrnbecher, T. (2014) · Infection and Immunity · doi:10.1128/iai.01700-14 · Cited by 28
Vascularized Osteomyocutaneous Allografts Are Permissive to Tolerance by Induction-Based Immunomodulatory Therapy
Lin, C., Zhang, W., Ng, T. W., Zhang, D., Jiang, J., Pulikkottil, B. J., Lakkis, F. G., Gorantla, V. S., Lee, W. P. A., Brandacher, G., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12275 · Cited by 28
Effects of different immunosuppressive regimens on regulatory T-cells in noninflamed colon of liver transplant recipients
Verdonk, R. C., Haagsma, E. B., Jonker, M. R., Bok, L. I. H., Zandvoort, J., Kleibeuker, J. H., Faber, K. N., & Dijkstra, G. D. H. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20087 · Cited by 28
Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunity
Wright, G. P., Ehrenstein, M. R., & Stauss, H. J. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.96 · Cited by 27
Induction of immunotolerance via mPEG grafting to allogeneic leukocytes
Wang, D., Toyofuku, W. M., Chen, A. M., & Scott, M. D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.061 · Cited by 27
Taming the lions: manipulating dendritic cells for use as negative cellular vaccines in organ transplantation
Turnquist, H. R., & Thomson, A. W. (2008) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328306116c · Cited by 27
Impaired T Cell Receptor Signaling in Foxp3+ CD4 T Cells
Carson, B. D., & Ziegler, S. F. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1394.022 · Cited by 27
Regulatory cells and cell signatures in clinical transplantation tolerance
Newell, K. A., Phippard, D., & Turka, L. A. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.008 · Cited by 26
Functional CD25bright+ alloresponsive T cells in fully immunosuppressed renal allograft recipients
Baan, C. C., Velthuis, J. H. L., van Gurp, E. A. F. J., Mol, W. M., Klepper, M., IJzermans, J. N. M., & Weimar, W. (2006) · Clinical Transplantation · doi:10.1111/j.1399-0012.2006.00584.x · Cited by 26
Good Manufacturing Practice-Compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory Disorders
Wiesinger, M., Stoica, D., Rößner, S., Lorenz, C., Fischer, A., Atreya, R. N., Neufert, C. F., Atreya, I., Scheffold, A., Schuler‐Thurner, B., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01371 · Cited by 27
Therapeutic use of T regulatory cells
Verbsky, J. W. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3280ad46bb · Cited by 26
Transplantation tolerance: Clinical potential of regulatory T cells
Müller, Y. D., Seebach, J. D., Bühler, L. H., Pascual, M. A., & Golshayan, D. (2011) · Self/Nonself · doi:10.4161/self.2.1.15422 · Cited by 25
Hyperexpression of Foxp3 and IDO During Acute Rejection of Islet Allografts
Yang, H., Ding, R., Sharma, V. K., Hilaire, F. S., Lagman, M., Li, B., Thomas, D. A., Luo, X., Song, P., Stauffer, C. E., et al. (2007) · Transplantation · doi:10.1097/01.tp.0000263991.74052.46 · Cited by 25
Generation, cryopreservation, function and in vivo persistence of ex vivo expanded cynomolgus monkey regulatory T cells
Guo, H., Zhang, H., Lu, L., Ezzelarab, M. B., & Thomson, A. W. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.02.006 · Cited by 25
Chronic Graft-versus-Host Disease: How Can We Release Prometheus?
Teshima, T., Wynn, T. A., Soiffer, R. J., Matsuoka, K., & Martin, P. J. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.10.023 · Cited by 25
Combined Administration of a Mutant TGF-β1/Fc and Rapamycin Promotes Induction of Regulatory T Cells and Islet Allograft Tolerance
Zhang, W., Zhang, D., Shen, M., Liu, Y., Tian, Y., Thomson, A. W., Lee, W. P. A., & Zheng, X. X. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000769 · Cited by 25
T-Regulatory Cells—What Relationship With Immunosuppressive Agents?
Wekerle, T. (2008) · Transplantation Proceedings · doi:10.1016/j.transproceed.2008.10.010 · Cited by 25
Checkpoint inhibitor use in two heart transplant patients with metastatic melanoma and review of high-risk populations
Grant, M. J., DeVito, N., & Salama, A. K. S. (2018) · Melanoma Management · doi:10.2217/mmt-2018-0004 · Cited by 24
T regulatory cells as an immunotherapy for transplantation
Albert, M. H., Anasetti, C., & Yu, X. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.4.315 · Cited by 24
Combined therapy of CD4+CD25+ regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice
Ma, A., Qi, S., Wang, Z., Massicotte, E., Dupuis, M., Daloze, P., & Chen, H. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.01.033 · Cited by 23
Monitoring of CD4+CD25highIL-7Rαhigh activated T Cells in Kidney Transplant Recipients
Vallotton, L., Hadaya, K., Venetz, J.-P., Buehler, L. H., Ciuffreda, D., Nseir, G., Deak, L. C., Villard, J., Pantaleo, G., & Pascual, M. A. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09611010 · Cited by 22
Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia
Dao, A. T. T., Yamazaki, H., Takamatsu, H., Sugimori, C., Katagiri, T., Maruyama, H., Zaimoku, Y., Maruyama, K., Ly, Q. T., Espinoza, L., et al. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2629-7 · Cited by 22
Novel everolimus-loaded nanocarriers for topical treatment of murine experimental autoimmune uveoretinitis (EAU)
Kasper, M., Gabriel, D., Möller, M., Bauer, D., Wildschütz, L., Courthion, H., Böhm, M. R. R., Busch, M., Loser, K., Thanos, S., et al. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.01.003 · Cited by 22
Suppressor Function of Umbilical Cord Blood-Derived CD4+CD25+ T-Regulatory Cells Exposed to Graft-versus-Host Disease Drugs
Porter, S. B., Liu, B., Rogosheske, J., Levine, B. L., June, C. H., Kohl, V., Wagner, J. E., Miller, J. S., & Blazar, B. R. (2006) · Transplantation · doi:10.1097/01.tp.0000225824.48931.af · Cited by 22
Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: an in-vitro study in healthy humans
Fanigliulo, D., Lazzerini, P. E., Capecchi, P. L., Ulivieri, C., Baldari, C. T., & Laghi-Pasini, F. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2014.12.021 · Cited by 21
Pediatric Lung Transplantation
Huddleston, C. B. (2010) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-010-0105-6 · Cited by 21
Management of patients with difficult autoimmune hepatitis
Parker, R., Oo, Y. H., & Adams, D. (2012) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12450251 · Cited by 21
Death receptor 3 signaling enhances proliferation of human regulatory T cells
Bittner, S., Knoll, G., & Ehrenschwender, M. (2017) · FEBS Letters · doi:10.1002/1873-3468.12632 · Cited by 21
The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation
Caballero‐Velázquez, T., Sánchez-Abarca, L. I., Gutierrez-Cosío, S., Blanco, B., Calderón, C., Herrero, C., Carrancio, S., Serrano, C. R., del Cañizo, C., Miguel, J. F. S., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.058677 · Cited by 21
The effect of sirolimus- or cyclosporine-based immunosuppression effects on T-cell subsets in vivo
Libetta, C., Sepe, V., Zucchi, M., Portalupi, V., Meloni, F., Rampino, T., & Canton, A. D. (2007) · Kidney International · doi:10.1038/sj.ki.5002255 · Cited by 21
The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+CD25− T cells
Kreijveld, E., Koenen, H. J. P. M., Hilbrands, L. B., van Hooff, H. P., & Joosten, I. (2006) · Blood · doi:10.1182/blood-2006-05-021931 · Cited by 21
Self-citation
Corticosteroids Do Not Reverse the Inhibitory Effect of Cyclosporine on Regulatory T-Cell Activity in Contrast to Mycophenolate Mofetil
Miroux, C., Moralès, O., Ouaguia, L., Aoudjehane, L., Boleslawski, E., Pancré, V., de Launoit, Y., Calmus, Y., Conti, F., & Delhem, N. (2012) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.09.091 · Cited by 18
Immunological advantages of everolimus versus cyclosporin A in liver‐transplanted recipients, as revealed by polychromatic flow cytometry
Roat, E., Biasi, S. D., Bertoncelli, L., Rompianesi, G., Nasi, M., Gibellini, L., Pinti, M., Giovane, C. D., Zanella, A., Benedetto, F. D., et al. (2012) · Cytometry Part A · doi:10.1002/cyto.a.22019 · Cited by 18
Optimization of in vitro expansion of macaque CD4+ T cells using anti‐CD3 and co‐stimulation for autotransfusion therapy
Onlamoon, N., Hudson, K. E., Bryan, P., Mayne, A. E., Bonyhadi, M. L., Berenson, R., Sundstrom, J. B., Boštík, P., Ansari, A. A., & Villinger, F. J. (2006) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2006.00182.x · Cited by 18
Flow Cytometry-Based Pharmacodynamic Monitoring After Organ Transplantation
Dieterlen, M., Eberhardt, K., Tárnok, A., Bittner, H. B., & Barten, M. J. (2011) · Methods in cell biology · doi:10.1016/b978-0-12-385493-3.00011-5 · Cited by 17
Intranasal Rapamycin Rescues Mice from Staphylococcal Enterotoxin B-Induced Shock
Krakauer, T., & Buckley, M. J. (2012) · Toxins · doi:10.3390/toxins4090718 · Cited by 17
Regulatory T Cells in Renal Transplantation and Modulation by Immunosuppression
López‐Hoyos, M., Segundo, D. S., Fernández‐Fresnedo, G., Marín, M. J., González-Martín, V., & Arias, M. (2009) · Transplantation · doi:10.1097/tp.0b013e3181af7b99 · Cited by 17
Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats
Wang, G., Zhang, Q., Yang, Y., Chen, W., Liu, W., Jiang, N., & Chen, G. (2012) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(12)60149-0 · Cited by 17
Antigen-Specific Regulatory T-Cell Subsets in Transplantation Tolerance
Koenen, H. J. P. M., & Joosten, I. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.05.007 · Cited by 17
Self-citation
Toll-like receptor 3 is an endogenous sensor of cell death and a potential target for induction of long-term cardiac transplant survival
Zhao, J., Huang, X., McLeod, P., Jiang, J., Liu, W., Haig, A. R., Jevnikar, A. M., Jiang, Z., & Zhang, Z. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16584 · Cited by 16
Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide
Elmariah, H., Otoukesh, S., Kumar, A., Ali, H., Arslan, S., Shouse, G., Pourhassan, H., Nishihori, T., Faramand, R. G., Mishra, A., et al. (2023) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2023.11.010 · Cited by 16
Increased frequency of regulatory T Cells and selection of highly potent CD62L+ cells during treatment of human lung transplant recipients with rapamycin
Lange, C. M., Tran, T. Y. V., Farnik, H., Jungblut, S., Born, T., Wagner, T. O. F., & Hirche, T. O. (2009) · Transplant International · doi:10.1111/j.1432-2277.2009.00973.x · Cited by 16
Ferrata Storti Foundation
Storti, F. (2008) · Cited by 16
The effects of immunosuppressive drugs on CD4+CD25+ regulatory T cells: a systematic review of clinical and basic research
Zhang, C., Shan, J., Feng, L., Lu, J., Xiao, Z., Luo, L., Li, C., Guo, Y., & Li, Y. (2010) · Journal of Evidence-Based Medicine · doi:10.1111/j.1756-5391.2010.01083.x · Cited by 15
Rapamycin combined with donor immature dendritic cells promotes liver allograft survival in association with CD4+CD25+Foxp3+ regulatory T cell expansion
Wang, G., Yang, Y., Li, H., Zhang, J., Li, M., Zhang, Q., & Chen, G. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00909.x · Cited by 15
Manipulation of Regulatory T-Cell Function by Immunomodulators: A Boon or a Curse?
Fort, M. M., & Narayanan, P. K. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq136 · Cited by 15
Role of antibodies to self-antigens in chronic allograft rejection: Potential mechanism and therapeutic implications
Sarma, N. J., Tiriveedhi, V., Angaswamy, N., & Mohanakumar, T. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.06.014 · Cited by 14
Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse?
Pidala, J., & Anasetti, C. (2009) · Haematologica · doi:10.3324/haematol.2009.015818 · Cited by 14
Regulatory T-cell subsets and their roles in transplantation tolerance
Chen, W., & Zhang, L. (2006) · Current Opinion in Organ Transplantation · doi:10.1097/01.mot.0000236699.52834.6f · Cited by 14
Immunotherapy with Regulatory T Cells in Transplantation
Peters, J. H., Koenen, H. J. P. M., Hilbrands, L. B., & Joosten, I. (2009) · Immunotherapy · doi:10.2217/imt.09.45 · Cited by 13
Self-citation
Exploiting beneficial alloreactive T cells
Barber, L. D., & Madrigal, J. A. (2006) · Vox Sanguinis · doi:10.1111/j.1423-0410.2006.00775.x · Cited by 13
Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development
Kim, D. D. H., Popradi, G., Lepic, K. L., Paulson, K., Allan, D., Nampoothiri, R. V., Lachance, S., Deotare, U., White, J., Elemary, M., et al. (2024) · Current Oncology · doi:10.3390/curroncol31030108 · Cited by 12
Harnessing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition
Zuber, J., Hermine, O., Chatenoud, L., & Legendre, C. M. (2011) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32834c237a · Cited by 11
Therapeutic Potential of Induced and Natural FoxP3+ Regulatory T Cells for the Treatment of Graft-Versus-Host Disease
Prinz, I., & Koenecke, C. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0172-3 · Cited by 11
IL-2-Mediated In Vivo Expansion of Regulatory T Cells Combined with CD154–CD40 Co-Stimulation Blockade but Not CTLA-4 Ig Prolongs Allograft Survival in Naive and Sensitized Mice
Govender, L., Wyss, J.-C., Kumar, R., Pascual, M. A., & Golshayan, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00421 · Cited by 11
Successful resolution of inflammation and increased regulatory T cells in sirolimus‐treated post‐transplant allograft hepatitis
Ekong, U. D., Mathew, J. M., Melín‐Aldana, H., Wang, D., & Alonso, E. M. (2012) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2012.01648.x · Cited by 11
Potential and limitations of regulatory T-cell therapy in solid organ transplantation
Govender, L., Pascual, M. A., & Golshayan, D. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.943191 · Cited by 12
Stabilizing Human Regulatory T Cells for Tolerance Inducing Immunotherapy
He, X., Koenen, H. J. P. M., Slaats, J., & Joosten, I. (2017) · Immunotherapy · doi:10.2217/imt-2017-0017 · Cited by 11
Self-citation
Regulatory T Cells in Transplantation: What We Know and What We Do Not Know
Yeung, M. Y., & Sayegh, M. H. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2009.06.093 · Cited by 11
Toward managing chronic rejection after lung transplant: The fate and effects of inhaled cyclosporine in a complex environment
Niven, R. W. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.004 · Cited by 10
T cell receptor beta chain (TCR-Vβ) repertoire of circulating CD4+CD25−, CD4+CD25lowand CD4+CD25highT cells in patients with long-term renal allograft survival
Velásquez, S. Y., Arias, L. F., GarcÃa, L. F., & Álvarez, C. M. (2009) · Transplant International · doi:10.1111/j.1432-2277.2009.00946.x · Cited by 10
Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats
Jäger, M. D., Liu, J. Y., Timrott, K., Popp, F., Stoeltzing, O., Lang, S. A., Piso, P., Geissler, E. K., Schlitt, H. J., & Dahlke, M. H. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.08.018 · Cited by 10
Rapamycin Treatment Alleviates Chronic GVHD-Induced Lupus Nephritis in Mice by Recovering IL-2 Production and Regulatory T Cells While Inhibiting Effector T Cells Activation
Zhang, J., Wang, X., Wang, R., Chen, G., Wang, J., Feng, J., Li, Y., Yu, Z.-Y., & He, X. (2023) · Biomedicines · doi:10.3390/biomedicines11030949 · Cited by 9
Human Peripheral Blood CD8+ CD28− T Cells of Renal Allograft Recipients Do Not Express FOXP3 Protein
Korecka, A., Duszota, A., Wierzbicki, P., Niemczyk, M., Bocian, K., Kłosowska, D., Pączek, L., Górski, A., & Korczak-Kowalska, G. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.08.016 · Cited by 9
Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV
Henrich, T. J., Bosch, R. J., Godfrey, C. C., Mar, H., Nair, A., Keefer, M. C., Fichtenbaum, C. J., Moisi, D. D., Clagett, B. M., Buck, A. M., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101745 · Cited by 9
Differential Sensitivity of Regulatory and Effector T Cells to Cell Death: A Prerequisite for Transplant Tolerance
You, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00242 · Cited by 8
Regulatory T-cell immunotherapy for allogeneic hematopoietic stem-cell transplantation
Horch, M., & Nguyen, V. H. (2011) · Therapeutic Advances in Hematology · doi:10.1177/2040620711422266 · Cited by 8
Pharmacologic Targeting of Regulatory T Cells for Solid Organ Transplantation: Current and Future Prospects
Safa, K., Chandran, S., & Wojciechowski, D. (2015) · Drugs · doi:10.1007/s40265-015-0487-6 · Cited by 8
The intragraft vascularized bone marrow induces secondary donor-specific mystacial pad allograft tolerance
Lin, C., Anggelia, M. R., Cheng, H.-Y., Hsieh, Y., Chuang, W., Yang, H., & Lin, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1059271 · Cited by 7
An update on the pharmacological management of autoimmune hepatitis
Chung, Y., Rahim, M. N., Graham, J. J., Zen, Y., & Heneghan, M. A. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1895747 · Cited by 7
Selective Effects of Cyclosporine A on Th2-Skewed Dendritic Cells Matured With Viral-Like Stimulus By Means of Toll-Like Receptors
Abdul, M., Charron, D. J., & Haziot, A. (2008) · Transplantation · doi:10.1097/tp.0b013e3181861f1d · Cited by 7
Kinetic analysis reveals potency of CD4+ CD25bright+ regulatory T-cells in kidney transplant patients
Velthuis, J. H. L., Hesselink, D. A., Hendrikx, T. K., van der Mast, B. J., Klepper, M., de Greef, G. E., Baan, C. C., & Weimar, W. (2007) · Transplant Immunology · doi:10.1016/j.trim.2007.05.009 · Cited by 7
De l’Ipex à foxp3 : une nouvelle contribution de la pédiatrie à la compréhension du système immunitaire
Marabelle, A., Meyer, M., Deméocq, F., & Lachaux, A. (2008) · Archives de Pédiatrie · doi:10.1016/j.arcped.2007.10.005 · Cited by 7
Overcoming barriers to widespread use of CAR‐Treg therapy in organ transplant recipients
Crémoni, M., Massa, F., & Sicard, A. (2022) · HLA · doi:10.1111/tan.14591 · Cited by 6
Induction of bona fide regulatory T cells after liver transplantation - the potential influence of polyclonal antithymocyte globulin
Stauch, D., Yahyazadeh, A., Bova, R., Melloh, G.-C., Füldner, A., Baron, U., Olek, S., Göldner, K., Weiß, S., Pratschke, J., et al. (2011) · Transplant International · doi:10.1111/j.1432-2277.2011.01405.x · Cited by 6
Oral immunosuppressive drugs
Khan, S., & Sewell, W. (2006) · Clinical Medicine · doi:10.7861/clinmedicine.6-4-352 · Cited by 6
Treating to re-establish tolerance in inflammatory arthritis – lessons from other diseases
Cooles, F. A. H., & Isaacs, J. D. (2010) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2010.01.007 · Cited by 6

Authors: Coenen, J. J. A., Koenen, H. J. P. M., van Rijssen, E., Hilbrands, L. B., & Joosten, I.
Affiliations: Radboud University Medical Center (NL)
From the Department of Bloodtransfusion and Transplantation Immunology and the Department of Nephrology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
ORCID: Koenen, Hans J. P. M.
Hilbrands, Luuk B.
Joosten, Irma
Venue: Blood
Publisher: American Society of Hematology
Published: 2006-02-01
Volume: 107
Issue: 3
Pages: 1018-1023
ISSN: 0006-4971 (ISSN-L)
1528-0020
DOI: 10.1182/blood-2005-07-3032
OpenAlex: W1972290737
Cited by: 252
References: 38
Citations by year: 2026: 3 · 2025: 4 · 2024: 4 · 2023: 5 · 2022: 2 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 4 · 2017: 14 · 2016: 9 · 2015: 13 · 2014: 14 · 2013: 8 · 2012: 21
FWCI: 8.16
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Blood (publishedVersion)
PubMed (publishedVersion)
Radboud Repository (Radboud University) (submittedVersion)
Funders: Nierstichting
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords: rapamycin, cyclosporine, regulatory T cells, CD4+CD25+ T cells, immunosuppressants, allograft tolerance, suppressor activity, mTOR inhibition
MeSH terms: Cells, Cultured, Dose-Response Relationship, Drug, Graft Rejection, Humans, Immune Tolerance, Immunosuppressive Agents, Isoantigens, Lymphocyte Activation, Transplantation, Homologous, Cyclosporine, Tumor Necrosis Factor Receptor Superfamily, Member 7, Sirolimus, T-Lymphocytes, Regulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks